Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients

Journal of Viral Hepatitis

Volumn 22, Issue 1, 2014, Pages 18-24

  Fuster, D ^a,b   Sanvisens, A ^a   Bolao, F ^c   Serra, I ^a   Rivas, I ^d   Tor, J ^a   Muga, R ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b BOSTON MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Municipal Centre for Substance Abuse Treatment (Centro Delta) IMSP   (Spain)

Author keywords

Alcohol dependence; HCV infection; Liver related mortality; Survival

Indexed keywords

ALCOHOL; METHADONE;

ACCOUNTING; ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DETOXIFICATION; DISEASE DURATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEROLOGY; COMORBIDITY; COMPLICATION; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL;

ADULT; ALCOHOLISM; COHORT STUDIES; COMORBIDITY; FEMALE; HEPATITIS C; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84926213250     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12290     Document Type: Article

References (38)

1. Schuckit MA. Alcohol-use disorders. Lancet 2009;373(9662):492-501.
2. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010;51(1):307-328.
3. Befrits R, Hedman M, Blomquist L et al. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol 1995;30(11):1113-1118.
4. Innes HA, Hutchinson SJ, Barclay S et al. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology 2013;57(2):451-460.
5. Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of drinking and drinking outcomes among drug misusers. 1-year follow-up results. J Subst Abuse Treat 2000;19(1):45-50.
6. Campbell JV, Hagan H, Latka MH et al. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 2006;81(3):259-265.
7. Stein MD, Hanna L, Natarajan R et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat 2000;18(4):359-363.
8. Rosman AS, Waraich A, Galvin K, Casiano J, Paronetto F, Lieber CS. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol 1996;91(3):498-505.
9. Stoller EP, Hund AJ, Webster NJ et al. Alcohol consumption within the context of hepatitis C: a qualitative study of non-problematic drinkers. Alcohol Alcohol 2006;41(5):546-552.
10. Lieber CS. Hepatitis C and alcohol. J Clin Gastroenterol 2003;36(2):100-102.
11. Fuster D, Tor J, Rey-Joly C, Muga R. Pathogenic interactions between alcohol and hepatitis C. Med Clin (Barc) 2012;138(14):627-632.
12. Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury. Hepatology 2006;43(2 Suppl 1):S194-S206.
13. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112(2):463-472.
14. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49(4):1335-1374.
15. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999;30(4):1054-1058.
16. Tural C, Fuster D, Tor J et al. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) coinfected patients. J Viral Hepat 2003;10(2):118-125.
17. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, META-VIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349(9055):825-832.
18. Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005;3(11):1150-1159.
19. Martinez-Raga J, Marshall EJ, Keaney F, Best D, Ball D, Strang J. Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit. Addict Biol 2001;6(4):363-372.
20. Tsui JI, Pletcher MJ, Vittinghoff E, Seal K, Gonzales R. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006;44(2):262-266.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. (DSM IV-TR). Washington, DC: Government Printing Office, 2000.
22. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360(26):2758-2769.
23. Muga R, Sanvisens A, Fuster D et al. Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One 2012;7(10):e46810.
24. Rivas I, Sanvisens A, Bolao F et al. Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders. Alcohol Clin Exp Res 2013;37(Suppl 1):E221-E227.
25. World Health Organization. International Statistical Classification of Diseases and Health Related Problems. Geneva: World Health Organization, 2007.
26. Obel N, Omland LH, Kronborg G et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One 2011;6(7):e22698.
27. Rosenthal E, Poiree M, Pradier C et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003;17(12):1803-1809.
28. John-Baptiste A, Krahn M, Heathcote J, Laporte A, Tomlinson G. The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and metaregression. J Hepatol 2010;53(2):245-251.
29. Harris DR, Gonin R, Alter HJ et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001;134(2):120-124.
30. McDonald SA, Hutchinson SJ, Mills PR et al. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population. J Viral Hepat 2011;18(4):e126-e133.
31. Shaw GK, Waller S, Latham CJ, Dunn G, Thomson AD. The detoxification experience of alcoholic inpatients and predictors of outcome. Alcohol Alcohol 1998;33(3):291-303.
32. Lahmek P, Berlin I, Michel L, Berghout C, Meunier N, Aubin HJ. Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme. Int J Med Sci 2009;6(4):160-167.
33. Schiff ER. Hepatitis C and alcohol. Hepatology 1997;26(3 Suppl 1):39S-42S.
34. Pineda JA, Romero-Gomez M, Diaz-Garcia F et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005;41(4):779-789.
35. Piasecki BA, Lewis JD, Reddy KR et al. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 2004;40(4):892-899.
36. Grebely J, Page K, Sacks-Davis R et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2014;59:109-120.
37. Omland LH, Christensen PB, Krarup H et al. Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. PLoS One 2011;6(7):e22476.
38. Fuster D, Cheng DM, Quinn EK et al. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction 2014;109:62-70.